Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease, Science, vol.288, issue.5466, pp.669-672, 2000. ,
DOI : 10.1126/science.288.5466.669
Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning, Science, vol.296, issue.5577, pp.2410-2413, 2002. ,
DOI : 10.1126/science.1070104
Murine Leukemia Induced by Retroviral Gene Marking, Science, vol.296, issue.5567, p.497, 2002. ,
DOI : 10.1126/science.1068893
LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1, Science, vol.302, issue.5644, pp.415-419, 2003. ,
DOI : 10.1126/science.1088547
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots, Cell, vol.110, issue.4, pp.521-529, 2002. ,
DOI : 10.1016/S0092-8674(02)00864-4
Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration, Science, vol.300, issue.5626, pp.1749-1751, 2003. ,
DOI : 10.1126/science.1083413
Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences, PLoS Biology, vol.100, issue.8, p.234, 2004. ,
DOI : 10.1371/journal.pbio.0020234.sd002
Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor Cells, PLoS Biology, vol.300, issue.12, p.423, 2004. ,
DOI : 10.1371/journal.pbio.0020423.st003
Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells, Blood, vol.101, issue.6, pp.2191-2198, 2003. ,
DOI : 10.1182/blood-2002-02-0627